These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1656753)

  • 1. Case report: increased insulin sensitivity in tumor hypoglycemia in a diabetic patient: glucose metabolism in tumor hypoglycemia.
    Barzilai N; Cohen P; Bar-Illan R; McIntyre N; Karnieli E
    Am J Med Sci; 1991 Oct; 302(4):229-34. PubMed ID: 1656753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation.
    Perseghin G; Mazzaferro V; Sereni LP; Regalia E; Benedini S; Bazzigaluppi E; Pulvirenti A; Leão AA; Calori G; Romito R; Baratti D; Luzi L
    Hepatology; 2000 Mar; 31(3):694-703. PubMed ID: 10706560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hepatocellular carcinoma with severe hypoglycemia: involvement of insulin-like growth factors.
    Yonei Y; Tanaka M; Ozawa Y; Miyazaki K; Tsukada N; Inada S; Inagaki Y; Miyamoto K; Suzuki O; Okawa H
    Liver; 1992 Apr; 12(2):90-3. PubMed ID: 1320177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS; Groop LC; Riely CA; DeFronzo RA
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.
    Tessari P; Nosadini R; Trevisan R; De Kreutzenberg SV; Inchiostro S; Duner E; Biolo G; Marescotti MC; Tiengo A; Crepaldi G
    J Clin Invest; 1986 Jun; 77(6):1797-804. PubMed ID: 3519679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
    Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
    J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemia in hepatocellular carcinoma: failure of short-term growth hormone administration to reduce enhanced glucose requirements.
    Wing JR; Panz VR; Joffe BI; Kalk WJ; Seftel HC; Zapf J; Kew MC
    Metabolism; 1991 May; 40(5):508-12. PubMed ID: 1850816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II.
    Shapiro ET; Bell GI; Polonsky KS; Rubenstein AH; Kew MC; Tager HS
    J Clin Invest; 1990 May; 85(5):1672-9. PubMed ID: 2159026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
    Plikat K; Reichle A; Elmlinger MW; Schölmerich J
    Dtsch Med Wochenschr; 2003 Feb; 128(6):257-60. PubMed ID: 12571793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatocellular carcinoma complicated by non-islet cell tumor hypoglycemia].
    van Wijngaarden P; Janssen JA; de Man RA
    Ned Tijdschr Geneeskd; 2002 May; 146(18):859-62. PubMed ID: 12038225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in man.
    Gray RS; Scarlett JA; Griffin J; Olefsky JM; Kolterman OG
    Diabetes; 1982 Oct; 31(10):929-36. PubMed ID: 6759226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metabolic clearance rate and hepatic extraction of insulin on hepatic and peripheral contributions to hypoglycemia.
    Chap Z; Ishida T; Chou J; Hartley CJ; Lewis RM; Entman M; Field JB
    J Clin Invest; 1985 Dec; 76(6):2222-34. PubMed ID: 3908485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo insulin action in hepatocellular and cholestatic liver cirrhosis.
    Barzilai N; Cohen P; Karnieli E; Enat R; Epstein O; Owen J; McIntyre N
    J Endocrinol Invest; 1991 Oct; 14(9):727-35. PubMed ID: 1761807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
    Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
    Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E; Barazzoni R; Tessari P
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect.
    Cavallo-Perin P; Cassader M; Bozzo C; Bruno A; Nuccio P; Dall'Omo AM; Marucci M; Pagano G
    J Clin Invest; 1985 May; 75(5):1659-65. PubMed ID: 3889056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
    Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
    Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
    Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
    Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.